Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal women-Reference-Cited by-同舟云学术

Aromatase Inhibitors for the adjuvant treatment of breast cancer in postmenopausal women

Published:2017-05-17 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Ali Asma¹,Kumar Vikaash Naveen-Chandra²,Shah Prakeshkumar S³,Warner Ellen⁴,Beyene Joseph⁵,Dent Rebecca⁶,Simmons Christine⁷

Affiliation:

1. Comprehensive Cancer Centre, King Fahad Medical City; Medical Oncology; Riyadh Saudi Arabia

2. Cancer Centre of Southeastern Ontario; Oncology; 25 King Street West Kingston ON Canada K7L 5P9

3. University of Toronto Mount Sinai Hospital; Department of Paediatrics and Institute of Health Policy, Management and Evaluation; 600 University Avenue Toronto ON Canada M5G 1XB

4. Sunnybrook Odette Cancer Centre; Medical Oncology; 2075 Bayview Avenue University of Toronto Toronto ON Canada M4N 3M5

5. McMaster University; Clinical Epidemiology and Biostatistics; 1280 Main Street West MDCL 3208 Hamilton ON Canada L8S 4K1

6. Duke-NUS Graduate Medical School Singapore; Medical Oncology, National Cancer Centre Singapore; Singapore Singapore

7. University of British Columbia; BC Cancer Agency; 600 West 10th Ave Vancouver BC Canada V5Z 4E6

Publisher

Wiley

Subject

Pharmacology (medical)

Link

https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011133.pub2/epdf/full

Reference49 articles.

1. Breast cancer survival by size and nodal status in Australia National Breast Cancer Centre & Australasian Association of Cancer Registries 2007

2. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis;Amir;Journal of the National Cancer Institute,2011

3. On the treatment of inoperable cases of carcinoma of the mamma: suggestions for a new method of treatment with illustrative cases;Beatson;Lancet,1896

4. A comparison of letrozole and tamoxifen in postmenopausal women with early breast cancer;Thürlimann;The New England Journal of Medicine,2005

5. Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: preliminary results of the Italian Tamoxifen Anastrozole Trial;Boccardo;Journal of Clinical Oncology,2005